Carregant...

Cost-Effectiveness of Sacral Neuromodulation versus OnabotulinumtoxinA for Refractory Urgency Urinary Incontinence: Results of the ROSETTA Randomized Trial

PURPOSE: Sacral neuromodulation and intradetrusor onabotulinumtoxinA injection are therapies for refractory urgency urinary incontinence. Sacral neuromodulation involves surgical implantation of a device that can last 4 to 6 years while onabotulinumtoxinA therapy involves serial office injections. W...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Urol
Autors principals: Harvie, Heidi S., Amundsen, Cindy L., Neuwahl, Simon J., Honeycutt, Amanda A., Lukacz, Emily S., Sung, Vivian W., Rogers, Rebecca G., Ellington, David, Ferrando, Cecile A., Chermansky, Christopher J., Mazloomdoost, Donna, Thomas, Sonia
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7204548/
https://ncbi.nlm.nih.gov/pubmed/31738113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JU.0000000000000656
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!